会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • BIOMOLECULE BINDING LIGANDS
    • 生物分子绑定配偶
    • WO2009007676A2
    • 2009-01-15
    • PCT/GB2008/002222
    • 2008-06-27
    • Cambridge Enterprise LimitedLOWE, Christopher RobinHUSSAIN, AbidMIMMACK, Michael LuisHAIGH, Jonathan Michael
    • LOWE, Christopher RobinHUSSAIN, AbidMIMMACK, Michael LuisHAIGH, Jonathan Michael
    • C07C309/15C07D277/56C07D417/12G01N33/543C07C309/51
    • C07C309/51B01D15/3804B01J20/286B01J20/289B01J20/3244B01J2220/54C07K1/22C40B30/04C40B40/04C40B50/14G01N33/531G01N33/532G01N33/54353Y10T436/143333Y10T436/145555Y10T436/147777Y10T436/17Y10T436/200833
    • The invention provides biomolecule binding ligands, collections of biomolecule binding ligands, and their use in the purification of biological mixtures and in the identification of ligands having an affinity for a substance. The ligand is a compound of formula (III) or a compound of formula (IV): wherein for compounds of formula (I) one of R 1a , R 1b ,R 2 , R 3 and R 4 is a group comprising a linker attached to a support, and the others of R 1a , R 1b , R 2 , R 3 and R 4 are independently selected from optionally substituted C 1-20 alkyl, optionally substituted C 3-20 heterocyclyl or optionally substituted C 5-20 aryl, and R 1a , R 1b and R 2 are additionally selected from hydrogen, and R 2 is additionally further selected from -S(=O)R 5 and -C(=S)NR 6 R 7 , wherein R 5 , R 6 and R 7 are independently optionally substituted C 1-20 alkyl, optionally substituted C 3-20 heterocyclyl or optionally substituted C 5-20 aryl, or, optionally, two or more of the others of R 1a , R 1b , R 2 , R 3 and R 4 , together with the atoms to which they are bound, may form a ring; and for compounds of formula (II) one of R 1a , R 1b , R 3 and R 4 isa group comprising a linker attached to a support, and the others of R 1a , R 1b , R 3 and R 4 are independently selected optionally substituted C 1-20 alkyl, optionally substituted C 3-20 heterocyclyl or optionally substituted C 5-20 aryl, and R 1a , and R 1b are additionally selected from hydrogen, or, optionally, two or more of the others of R 1a , R 1b , R 3 and R 4 , together with the atomsto which they are bound, may form a ring.
    • 本发明提供了生物分子结合配体,生物分子结合配体的集合,以及它们在纯化生物混合物中的用途以及鉴定对物质具有亲和力的配体。 配体是式(III)化合物或式(Ⅳ)化合物:其中对于式(I)化合物,R 1a,R 1b,R 2,R 3和R 4中的一个是包含连接于载体上的连接基团, 其中R1a,R1b,R2,R3和R4独立地选自任选取代的C 1-20烷基,任选取代的C 3-20杂环基或任选取代的C 5-20芳基,并且R 1a,R 1b和R 2另外选自氢,并且R 2是 另外还选自-S(= O)R 5和-C(= S)NR 6 R 7,其中R 5,R 6和R 7独立地是任选取代的C 1-20烷基,任选取代的C 3-20杂环基或任选取代的C 5-20芳基,或 任选地,R 1a,R 1b,R 2,R 3和R 4中的两个或更多个与它们所结合的原子一起形成环; 并且对于式(II)化合物,R 1a,R 1b,R 3和R 4中的一个是包含连接于载体的连接体的基团,R 1a,R 1b,R 3和R 4中的其它基团独立地选自任选被取代的C 1-20烷基, C 3-20杂环基或任选取代的C 5-20芳基,并且R 1a和R 1b另外选自氢,或任选地,R 1a,R 1b,R 3和R 4中的两个或多个,以及它们所结合的原子团 ,可能会形成一个戒指。